Market revenue in 2023 | USD 376.6 million |
Market revenue in 2030 | USD 560.4 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Endoscopes |
Fastest growing segment | Single Photon Emission Computed Tomography (SPECT) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscopes, X-ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) |
Key market players worldwide | Koninklijke Philips NV, Medtronic PLC, Siemens Healthineers AG ADR, Analogic Corporation, GE HealthCare Technologies Inc Common Stock, BrainLAB, Olympus Corp, Stryker Corp, Varian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to image-guided therapy systems market will help companies and investors design strategic landscapes.
Endoscopes was the largest segment with a revenue share of 32% in 2023. Horizon Databook has segmented the Japan image-guided therapy systems market based on computed tomography (ct) scanners, ultrasound systems, magnetic resonance imaging (mri), endoscopes, x-ray fluoroscopy, positron emission tomography (pet), single photon emission computed tomography (spect) covering the revenue growth of each sub-segment from 2018 to 2030.
Globally, Japan has one of the largest geriatric population. Approximately one in three Japanese citizens is aged 60 years or above, and aging increases susceptibility to contracting chronic diseases & complex comorbidities.
Increasing prevalence of chronic diseases has led to an increase in the number of diagnostic imaging tests being performed in the country. Furthermore, supportive government initiatives are anticipated to positively impact the market.
For instance, in 2018, Japanese Ministry of Health, Labor and Welfare (MHLW) granted Shonin approval to ViewRay, Inc to market its MRIdian Linac System, an MRI-guided radiation therapy system, making it the first of its kind to receive Shonin approval in the country, further promoting the adoption of advanced technologies in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan image-guided therapy systems market , including forecasts for subscribers. This country databook contains high-level insights into Japan image-guided therapy systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account